"Le CHU demande aux usagers de présenter à l’entrée de ses sites hospitaliers un « pass sanitaire », pour accéder au CHU. Ces consignes ne s’appliquent pas : - aux urgences adultes, pédiatriques, gynécoobstétriques, odontologiques et ophtalmologiques ; Plus d'infos sur le site internet du CHU"

During the past decade, Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B" are "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B" in a lesser frequency.

Most popular intervention types in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (9 trials), "Placebo" (4 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials) and "Avonex" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".